Unilateral Sanctions Undermine Effective Counter-Narcotics Strategies

Unilateral Sanctions Undermine Effective Counter-Narcotics Strategies

Imposing unfair sanctions against Iran has significant implications for the country’s ability to implement treatment and harm reduction programs. This issue affects the development of effective strategies to combat drug trafficking, according to Brigadier General Hossein Zolfaqari, the Secretary General of the Iranian Drug Control Headquarters (DCHQ). His remarks were made during the 68th session of the United Nations Commission on Narcotic Drugs (CND) held from March 10 to 14 in Vienna, Austria.

Zolfaqari emphasized the evolving global drug problem, acknowledging the efforts of the United Nations Office on Drugs and Crime (UNODC) while addressing the challenges posed by new psychoactive substances (NPS). The following key points summarize his address:

  • Challenges from Sanctions: Sanctions increase the costs and complexities of implementing drug treatment and harm reduction programs.
  • Emergence of New Psychoactive Substances: National and international drug control systems are struggling to cope with the rapid emergence of NPS.
  • Need for Cooperation: Zolfaqari called for enhanced cooperation, information exchange, and technical assistance among countries.
  • Diversifying Treatment Methods: Expanding access to medical drugs and diversifying treatment methods are crucial for reducing illegal drug use.

In his speech, Zolfaqari proposed various methods to improve drug treatment strategies, emphasizing the importance of:

  1. Strengthening mechanisms for sharing experiences and best practices.
  2. Providing technical assistance and necessary equipment to affected countries.
  3. Transferring essential technologies to combat illegal drug production and consumption.

He also highlighted the importance of restoring successful initiatives that have been halted or are only partially active. For instance, the agreement involving Iran, Afghanistan, and Pakistan, supported by the UNODC, aimed at enhancing cooperation in counter-narcotics enforcement. Zolfaqari urged the international community to fund the UNODC to support regional agreements effectively.

“In line with the implementation of numerous resolutions of the CND and the Human Rights Council, we call for an end to sanctions and the procurement of effective technical and equipment assistance to countries on the front lines of the fight against drugs,” he noted.

During the CND session, Zolfaqari will not only deliver a high-level speech but will also engage in bilateral and multilateral discussions with officials from the Narcotics Commission, the Executive Director of the UNODC, and other international delegates. These meetings are aimed at fostering collaboration and sharing insights on drug control strategies.

Moreover, the UNODC’s support will facilitate the sharing of Iran’s experiences in harm reduction, prevention, treatment, rehabilitation, and the reintegration of recovered individuals into society. This exchange will inform participants, specialists, and experts about the measures taken by Iran in these areas.

Understanding the Commission on Narcotic Drugs (CND)

The CND serves as the central policy-making body within the United Nations system, addressing a wide range of drug-related issues. Its main functions include:

  • Examining the global drug situation and promoting international drug control mechanisms.
  • Identifying the effectiveness of international institutions in drug control.
  • Reviewing the implementation of international conventions on narcotics and psychotropic substances.
  • Providing recommendations to strengthen international drug control activities.
  • Facilitating scientific research and information exchange on drug-related matters.

By addressing interrelated issues of drug demand, supply, and trafficking, the CND plays a critical role in supporting the Economic and Social Council (ECOSOC) of the United Nations. It establishes policies that govern the activities of the UNODC and manages its financial resources.

As the global drug landscape continues to evolve, the discussions at the CND underscore the need for collective action and innovative strategies to combat drug trafficking and address the challenges posed by substance abuse.

Brigadier General Zolfaqari’s insights during this session reflect Iran’s commitment to improving drug control efforts while advocating for international cooperation and support amidst the challenges posed by sanctions and new drug trends.

Similar Posts

  • This article will be expanded with more detailed information shortly. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information…

  • Tehran and Kabul Unite: Strengthening Health Cooperation for a Brighter Future

    Iranian and Afghan officials are enhancing cooperation in the pharmaceutical and medical equipment sectors to improve healthcare services for their populations. A significant meeting between Mehdi Pirsalehi, head of Iran’s Food and Drug Administration, and his Afghan counterpart, Mawlawi Hamdullah Zahid, resulted in a memorandum of understanding focusing on food, drug, and medical equipment collaboration. The discussions addressed medical product registration, licensing timelines, and import procedures during the Afghan Health Exhibition in Kabul. Iran aims for self-sufficiency in medical supplies, with over 99% of its medicine produced domestically. This partnership seeks to benefit both nations’ health systems and local production.

  • New Funding Boost: Special Budget Set Aside for Rare and Challenging Diseases

    The Iranian government has allocated 120 billion rials (approximately $144,000) to enhance healthcare access for rare diseases, which affect over 300 million people globally. The Salamat Health Insurance Organization, in partnership with the Ministry of Health, established the Rare Disease Foundation to reduce out-of-pocket costs and promote health equity. Currently, it covers 130 rare diseases, benefiting over 2.5 million patients. The foundation focuses heavily on cancer treatments, which consume about 70% of its budget. Celebrated on May 8, World Thalassemia Day raises awareness of thalassemia, which affects over 19,000 patients in Iran, highlighting the need for comprehensive care.

  • New School Regulations Tighten Security Measures in Iran’s Classrooms

    The revised “Executive School Bylaw” in Iran has sparked serious concerns among educators, parents, and child-rights advocates due to its expansion of surveillance and disciplinary control in schools. Key changes include increased authority for principals, strict mobile phone regulations, and the installation of surveillance cameras. While officials argue these measures adapt to modern education, critics warn they compromise student safety and freedom, reinforcing a trend of political and ideological oversight. A recent incident of violence at a girls’ school highlights the troubling normalization of aggression in educational settings. The bylaw is viewed as a political tool to control future generations.

  • Over 1,140 Iranians Join Elite Ranks of World’s Top 1% Most-Cited Researchers

    In 2025, Iran’s academic community achieved a milestone with 1,142 researchers recognized among the top one percent of most-cited researchers, up from 1,056 in 2024, according to the Islamic World Science Citation Institute. The Ministry of Health leads with 603 entries, while the Ministry of Science follows with 427. Key fields include Clinical Medicine, Engineering, and Pharmacology. Additionally, Stanford University identified 2,772 Iranian researchers among the top two percent based on career-long impact. This growth reflects a significant improvement in Iran’s scientific production quality, with 2,533 highly cited researchers recorded in the 2025-2026 period.

  • Shocking Surge: Over 600 Earthquakes Rattle Iran in Just One Month!

    Iran has experienced significant seismic activity recently, recording 602 earthquakes between October 23 and November 21, with the strongest measuring 4.7 in Yazd Province on November 1. Most quakes were minor, with 528 below magnitude 3. Over the past year, the country documented 6,272 earthquakes, including 150 exceeding magnitude 4. Despite only representing 2% of global earthquakes, Iran has faced over 6% of related casualties in the 20th century. This highlights the need for improved disaster preparedness and response strategies, emphasizing the importance of ongoing monitoring and public awareness to mitigate earthquake impacts.